Immunocore Holdings plc (IMCR) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$3.00M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $7.28M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$7.17M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$14.88M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2021-12-31 to 2025-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$3.00M | (m) | $115.93M | (m) | $786.00K* | $15.93M* | (m) | $73.94M | $43.89M | $294.00K |
|---|
| 2026-03-31 | Reported | (m) | $7.28M | (m) | $106.68M | (m) | $1.78M | -$13.78M | (m) | $61.11M | $37.85M | $301.00K |
|---|
| 2025-09-30 | Reported | (m) | -$7.17M | (m) | $103.69M | (m) | $748.00K* | -$4.46M* | (m) | $70.57M | $39.78M | $481.00K |
|---|
| 2025-06-30 | Reported | (m) | -$14.88M | (m) | $97.96M | (m) | $414.00K* | $25.96M* | (m) | $69.01M | $42.79M | $606.00K |
|---|
| 2025-03-31 | Reported | (m) | -$3.62M | (m) | $93.88M | (m) | $298.00K | $435.00K | (m) | $56.47M | $40.20M | $1.06M |
|---|
| 2024-09-30 | Reported | (m) | -$8.50M | (m) | $80.25M | (m) | $828.00K* | $21.13M* | (m) | $52.77M | $35.53M | -$2.64M |
|---|
| 2024-06-30 | Reported | (m) | -$16.02M | (m) | $75.40M | (m) | $331.00K* | $23.47M* | (m) | $51.07M | $38.64M | $1.49M |
|---|
| 2024-03-31 | Reported | (m) | -$26.49M | (m) | $70.50M | (m) | $430.00K | -$4.59M | (m) | $57.46M | $39.29M | $357.00K |
|---|
| 2023-09-30 | Reported | (m) | -$14.14M | (m) | (m) | (m) | $212.00K* | $10.09M* | (m) | $43.25M | $35.47M | -$175.00K |
|---|
| 2023-06-30 | Reported | (m) | -$13.76M | (m) | (m) | (m) | $1.40M* | $45.00K* | (m) | $38.16M | $35.01M | $191.00K |
|---|
| 2023-03-31 | Reported | (m) | -$14.70M | (m) | (m) | (m) | $3.00M | $10.54M | (m) | $36.57M | $32.57M | $293.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$42.25M | (m) | (m) | (m) | -10.56% | $4.34M | -$10.71M | (m) | $274.87M | $165.41M | $16.41M |
|---|
| 2024-12-31 | Reported | -$66.26M | (m) | (m) | (m) | -21.36% | $5.17M | $26.06M | (m) | $222.15M | $155.78M | -$1.85M |
|---|
| 2023-12-31 | Reported | -$55.55M | (m) | (m) | (m) | -22.27% | $5.42M | $2.94M | (m) | $163.54M | $144.50M | -$5.60M |
|---|
| 2022-12-31 | Reported | -$46.41M | (m) | (m) | (m) | -26.62% | $2.20M | -$49.21M | (m) | $101.92M | $123.06M | $11.66M |
|---|
| 2021-12-31 | Reported | -$166.99M | (m) | (m) | (m) | -4094.83% | $1.39M | -$143.11M | (m) | $100.25M | $110.82M | $150.00K |
|---|